The Jackson Laboratory, Bar Harbor, ME, USA.
Nat Immunol. 2010 Sep;11(9):820-6. doi: 10.1038/ni.1909. Epub 2010 Jul 25.
Activation-induced cytidine deaminase (AID) is required for somatic hypermutation and immunoglobulin class switching in activated B cells. Because AID has no known target-site specificity, there have been efforts to identify non-immunoglobulin AID targets. We show here that AID acts promiscuously, generating widespread DNA double-strand breaks (DSBs), genomic instability and cytotoxicity in B cells with less homologous recombination ability. We demonstrate that the homologous-recombination factor XRCC2 suppressed AID-induced off-target DSBs, promoting B cell survival. Finally, we suggest that aberrations that affect human chromosome 7q36, including XRCC2, correlate with genomic instability in B cell cancers. Our findings demonstrate that AID has promiscuous genomic DSB-inducing activity, identify homologous recombination as a safeguard against off-target AID action, and have implications for genomic instability in B cell cancers.
激活诱导胞嘧啶脱氨酶(AID)是体细胞高频突变和活化 B 细胞中免疫球蛋白类别转换所必需的。由于 AID 没有已知的靶位特异性,因此人们一直在努力寻找非免疫球蛋白 AID 靶位。我们在这里显示,AID 表现出混杂性,在同源重组能力较弱的 B 细胞中产生广泛的 DNA 双链断裂(DSB)、基因组不稳定性和细胞毒性。我们证明,同源重组因子 XRCC2 抑制 AID 诱导的非靶标 DSB,促进 B 细胞存活。最后,我们提出,影响人类染色体 7q36 的异常,包括 XRCC2,与 B 细胞癌症中的基因组不稳定性相关。我们的发现表明,AID 具有混杂的基因组 DSB 诱导活性,鉴定出同源重组是防止 AID 非靶标作用的一种保护机制,并对 B 细胞癌症中的基因组不稳定性具有重要意义。